Efficiency and safety of application of combined scheme with ursodeoxycholic acid and mebeverin preparations in patients with metabolic syndrome

The article presents the clinical assessment data for efficiency and safety of hepatoprotector and spasmolytic administration in patients with metabolic syndrome. Application of ursodeoxycholic acid preparation in 500 mg dosage, and selective spasmolytic based on mebeverin, contribute to significant...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu. P. Uspensky, N. V. Baryshnikova, Yu. A. Fominykh, R. M. Niyazov, D. V. Zakharov
Format: Article
Language:Russian
Published: Open Systems Publication 2021-06-01
Series:Лечащий Врач
Subjects:
Online Access:https://journal.lvrach.ru/jour/article/view/561
Tags: Add Tag
No Tags, Be the first to tag this record!